drugset / Trial / NCT00168571
Long-term Follow-up of Measles Antibodies
Phase 4
Completed
1960 enrolled
Bandim Health Project
Danish Council for Development Research · collabFonden til Lægevidenskabens Fremme · collabMedical Research Council Unit, The Gambia · collabNovo Nordisk A/S · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
Few data exist on long-term persistence of measles antibodies after vaccination of West African infants. The data that do exist indicate that the antibody titres decline very rapidly. Our data would be the first to describe the persistence of measles antibodies after two doses of measles vaccine, and the study would allow us to identify unprotected children and offer them revaccination. Since persistence of measles antibodies is of crucial importance to measles control, the study will contribute significantly to the existing knowledge and might have important implications for future eradication programmes.
Timeline
- Start
- 2002-03
- Primary completion
- —
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Measles vaccine | Vaccine | — | — |